Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-8kt4b Total loading time: 0 Render date: 2024-06-27T09:01:23.578Z Has data issue: false hasContentIssue false

Chapter 31 - Thromboprophylaxis for the Obese Surgical Patient

from Section 5 - Post-operative Care

Published online by Cambridge University Press:  24 September 2018

Christopher Bouch
Affiliation:
Leicester Royal Infirmary
Jonathan Cousins
Affiliation:
Hammersmith Hospital
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Further Reading

Alikhan, R, Peters, F, Wilott, R, Cohen, AT Fatal pulmonary embolism in hospitalised patients: anecropsy review. J Clin Pathol. 2004;54:1254–7.Google Scholar
Bartlett, MA, Mauck, KF, Daniels, PR Prevention of venous thromboembolism in patients undergoing bariatric surgery. Vasc Health Risk Manag. 2015;11:461–77.Google ScholarPubMed
Becattini, C, Agnelli, G, Manina, G, Noya, G, Rondelli, F Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. Surg Obes Relat Dis. 2012;8:108–15.CrossRefGoogle ScholarPubMed
Birkmeyer, NJ, Share, D, Baser, O, et al.; Michigan Bariatric Surgery Collaborative. Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgery. Ann Surg. 2010;252:313–18.Google ScholarPubMed
Birkmeyer, NJ, Finks, JF, Carlin, AM, et al.; Michigan Bariatric Surgery Collaborative. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery. Arch Surg. 2012;147(11):994–8.Google Scholar
Borkgren-Okonek, MJ, Hart, RW, Pantano, JE, et al. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity. Surg Obes Relat Dis. 2008;4:625–31.Google Scholar
Celik, F, Huitema, A, Hooijberg, J, et al. Fixed dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels. Obes Surg. 2015;25:628–34.Google Scholar
Diepstraten, J, Janssen, EJ, Hackeng, CM, et al. Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint. Eur J Clin Pharmacol. 2015;71(1):2534.CrossRefGoogle ScholarPubMed
Edmonds, MJ, Crichton, TJ, Runciman, WB, Pradhan, M Evidence-based risk factors for postoperative deep vein thrombosis. ANZ J Surg. 2004;74:1082–97.CrossRefGoogle ScholarPubMed
Finks, JF, English, WJ, Carlin, AM, et al.; Michigan Bariatric Surgery Collaborative Center for Healthcare Outcomes and Policy. Predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Ann Surg. 2012;255:1100–4.Google Scholar
Frantzides, CT, Welle, SN, Ruff, TM, Frantzides, AT Routine anticoagulation for venous thromboembolism prevention following laparoscopic gastric bypass. JSLS. 2012;16:33–7.Google Scholar
Gould, MK, Garcia, DA, Wren, SM, et al.; American College of Chest Physicians. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e227S77SGoogle Scholar
Hamad, GG, Choban, PS Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005;15:1368–74.CrossRefGoogle ScholarPubMed
Ho, KM, Tan, JA Stratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent thromboembolism in hospitalised patients. Circulation. 2013;128:1003–20.CrossRefGoogle Scholar
Imberti, D, Baldini, E, Pierfranceschi, MG, et al. Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomized pilot study evaluating two doses of parnaparin (BAFLUX Study). Obes Surg. 2014;24:284–91.Google Scholar
Kalfarentzos, F, Stavropoulou, F, Yarmenitis, S, et al. Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial. Obes Surg. 2001;11:670–6.CrossRefGoogle ScholarPubMed
Keeling, D, Campbell Tait, R, Watson, H Peri-operative management of anticoagulation and antiplatelet therapy. 2016. www.bcshguidelines.com/documents/BSH_periop_guideline_for_editor.pdf (accessed May 2018).Google Scholar
Kothari, SN, Lambert, PJ, Mathiason, MA A comparison of thromboembolic and bleeding events following laparoscopic gastric bypass in patients treated with prophylactic regimens of unfractionated heparin or enoxaparin. Am J Surg. 2007;194(6):709–11.Google Scholar
Lester, W, Freemantle, N, Begaj, I, et al. Fatal venous thromboembolism associated with hospital admission: a cohort study to assess the impact of a national risk assessment target. Heart. 2013;99:1734–9.Google Scholar
Martin, K, Beyer-Westendorf, J, Davidson, BL, et al. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. J Thromb Haemost 2016;14:1308–13.CrossRefGoogle ScholarPubMed
Mismetti, P, Laporte, S, Darmon, JY, Buchmüller, A, Decousus, H Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001;88:913–30.Google Scholar
NICE. Clinical guideline CG92: Venous Thromboembolism: Reducing the Risk of Venous Thromboembolism in Patients Admitted to Hospital. http://guidance.nice.org.uk/CG92 (accessed May 2018).Google Scholar
Nutescu, EA, Spinler, SA, Wittkowsky, A, Dager, WE Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. Ann Pharmacother. 2009;43:1064–83.Google Scholar
Roberts, LN, Porter, G, Barjer, RD et al. Comprehensive VTE prevention programme incorporating mandatory risk assessment reduces the incidence of hospital-associated thrombosis. Chest. 2013.;144:1276–81.CrossRefGoogle ScholarPubMed
Rocha, AT, de Vasconcellos, AG, da Luz Neto, ER, et al. Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery. Obes Surg. 2006;16:1645–55.Google Scholar
Roftopoulous, I, Martindale, C, Cronin, A et al. The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc. 2008;22:2384–91.Google Scholar
Rowan, BO, Kuhl, DA, Lee, MD, Tichansky, DS, Madan, AK Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin. Obes Surg. 2008;18:162–6.Google Scholar
Sachdeva, A, Dalton, M, Amaragiri, SV et al. Graduated compression stockings for prevention of deep vein thrombosis. Cochr Database Syst Rev. 2014;12:CD001484.Google Scholar
Scholten, D, Hoedema, R, Scholten, S A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg. 2002;12:1924.CrossRefGoogle ScholarPubMed
Simoneau, MD, Vachon, A, Picard, F Effect of prophylactic dalteparin on anti-factor Xa levels in morbidly obese patients after bariatric surgery. Obes Surg. 2010;20:487–91.CrossRefGoogle ScholarPubMed
Diepstraten, J, Hackeng, C, van Kralingen, S et al. Anti-Xa levels 4 h after subcutaneous administration of 5,700 units IU nadroparin strongly correlate with lean body weight in morbidly obese patients. Obes Surg. 2012;22:791–6.CrossRefGoogle Scholar
Winegar, DA, Sherif, B, Pate, V, DeMaria, EJ Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2011;7:181–8.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×